does glp 1 affect birth control tirzepatide and oral contraceptives GLP-1s can control… (yes, you read that right!) If you're taking tirzepatide, here's what our pharmacist wants you to know., #Tirzepatide #BirthControl #GLP1 Tirzepatide and Birth GLP-1s can affect oral birth

They serve different purposes and stack well together in regenerative protocols

GLP-3 & Cagrilintide Blend is a dual-peptide blend containing GLP-3 10mg and Cagrilintide 10mg

In research applications, the pH of bacteriostatic water (averaging 5.7) is generally compatible with the stability profiles of most peptide structures, allowing for extended storage of reconstituted solutions at 28C compared to sterile water alone

Hypothetical Conservative Combination Protocol A conservative approach to combining these peptides would likely involve: Phase 1: Tirzepatide Establishment (Weeks 1-12) Week 1-4: Tirzepatide 2.5 mg weekly Week 5-8: Tirzepatide 5 mg weekly Week 9-12: Tirzepatide 7.5 mg weekly Cagrilintide: None (establish baseline tolerance) Phase 2: Cagrilintide Introduction (Weeks 13-20) Week 13-16: Tirzepatide 7.5 mg + Cagrilintide 0.6 mg weekly Week 17-20: Tirzepatide 7.5 mg + Cagrilintide 1.2 mg weekly Phase 3: Optimization (Week 21+) Tirzepatide 10-12.5 mg + Cagrilintide 2.4 mg weekly Adjust based on tolerance and response "The key principle when considering any peptide combination is sequential introduction with careful monitoring of tolerability markers, particularly gastrointestinal symptoms that could compound across mechanisms." This theoretical framework prioritizes safety through staged introduction, though actual clinical protocols would require medical supervision and monitoring

Ignoring the enteric coating assumption Many capsule products are not enteric-coated and rely entirely on the acid-stability argument